Latest News

 Filter by Provider

Did the fund that beat the hedge funds keep that up after the bet was over?

There are hundreds of billions at stake and fears that AI spending is creating an unsustainable bubble.

OmniAb (NASDAQ:OABI) Chief Financial Officer Kurt Gustafson outlined the company’s antibody-discovery platform, partner pipeline and revenue model during a company presentation, emphasizing a strategy built around licensing technology to pharmaceutical and biotechnology companies rather than develop

Shares of Meta have dropped nearly 10% this week.

Property casualty insurer Cincinnati Financial (NASDAQ:CINF) will be announcing earnings results this Monday after market hours. Here’s what to look for. Cin...

Home appliances manufacturer Whirlpool (NYSE:WHR) will be reporting earnings this Monday after market close. Here’s what investors should know. Whirlpool mis...

U.S. citizens will head to the polls on Nov. 3 to vote in a slate of races in both the U.S. House of Representatives and the U.S. Senate.

Rail transportation company Greenbrier (NYSE:GBX) will be reporting earnings this Monday after market close. Here’s what to expect. Greenbrier missed analyst...

Insurance brokerage firm Brown & Brown (NYSE:BRO) will be reporting results this Monday after market close. Here’s what investors should know. Brown & Brown ...

Hospitality software provider Agilysys (NASDAQ:AGYS) will be announcing earnings results this Monday after market hours. Here’s what to look for. Agilysys be...

Telecommunications giant Verizon (NYSE:VZ) will be reporting results this Monday before the bell. Here’s what to look for. Verizon missed analysts’ revenue e...

Insurance and financial services company The Hartford (NYSE:HIG) will be announcing earnings results this Monday afternoon. Here’s what you need to know. Har...

Semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) will be reporting results this Monday afternoon. Here’s what you need to know. Amk...

Regional banking company Lakeland Financial (NASDAQGS:LKFN) will be reporting earnings this Monday before market open. Here’s what you need to know. Lake Cit...

Offshore drilling contractor Noble Corporation (NYSE:NE) will be reporting results this Monday after market hours. Here’s what investors should know. Noble C...

Electronic design automation company Cadence Design Systems (NASDAQ:CDNS) will be reporting earnings this Monday after the bell. Here’s what investors should...

Professional staffing firm Kforce (NYSE:KFRC) will be announcing earnings results this Monday after the bell. Here’s what to expect. Kforce met analysts’ rev...

Regional banking institution Bank of Hawaii (NYSE:BOH) will be reporting earnings this Monday before market hours. Here’s what to expect. Bank of Hawaii met ...

FitLife Brands (NASDAQ:FTLF) outlined its strategy to grow a portfolio of nutritional supplement and wellness brands through acquisitions, e-commerce sales and operational improvements, while acknowledging recent organic-growth headwinds tied to Amazon changes, specialty retail traffic and weakening

Heavy equipment distributor Custom Truck One Source (NYSE:CTOS) will be reporting results this Monday after market close. Here’s what to expect. Custom Truck...

Building products manufacturer Simpson (NYSE:SSD) will be reporting earnings this Monday after market hours. Here’s what you need to know. Simpson beat analy...

Regional banking company Northwest Bancshares (NASDAQ:NWBI) will be announcing earnings results this Monday after the bell. Here’s what to look for. Northwes...

Constellation and Vistra do similar things, while GE Vernova is a picks-and-shovels play, which is a big growth opportunity.

Strawberry Fields REIT (NYSEAMERICAN:STRW) Chairman, CEO and founder Moishe Gubin outlined the skilled nursing facility real estate investment trust’s growth strategy, lease structure and demographic outlook, emphasizing recurring rent collections and a disciplined acquisition model. Gubin said the

Rocket Lab is keeping us waiting for Neutron.

The company's massive backlog grew 27% this quarter and is approaching $300 billion.

AMD's stock is just too pricey to consider buying right now.

Is the AI boom becoming a bubble?

Projecting a staggering $1 trillion annual revenue run rate by the end of 2027, SpaceX is transforming into an AI powerhouse.

Warren Buffett has carefully chosen how Berkshire Hathaway is positioned for the artificial intelligence (AI) revolution.

Rocket Lab has emerged as a top competitor to SpaceX in launch services.

Apple and Tesla are unveiling futuristic products, but are they solving real problems or just creating new ones?

Can the delivery giant's leaner network make enough to back a 6.5% yield?

Exelixis will have to wait longer than expected to earn approval for a new drug. It's not the end of the world.

Booking's 20% net margin and $9.1B free cash flow contrast sharply with Chewy's 1.8% margin, but their valuations tell a different story.

Amgen (NASDAQ:AMGN) presented Phase III data at the European Society for Medical Oncology Congress 2026 showing that its DLL3-targeting BiTE therapy IMDELLTRA, when added to durvalumab maintenance treatment, improved survival outcomes for patients with extensive-stage small-cell lung cancer whose di

When you think “companies Berkshire Hathaway likes”, often we think of mature, almost iconic businesses that have produced consistent results for years. Bending Spoons, an acquirer of legacy digital assets, doesn’t really fit the mold. Today, though, Matt, Jon, and Tyler take a closer look at why Berkshire is buying this Milan-based business and why it may be closer to the prototypical Berkshire business. Plus, emptying the analyst notebook on earnings and distressed debt is hitting neoclouds

Advance Auto Parts is burning cash while Etsy generates $639 million in free cash flow, a stark divide that frames the real risk-reward trade-off.

Palantir stock has risen more than 700% over the last five years. Is a stock split in the cards?

Deposit discipline and share buybacks are amplifying per-share earnings as interest rates reset higher.

The company's gene-editing-focused platform looks promising.

Booking's 20% net margin and $9.1 billion in free cash flow stack against Five Below's aggressive 22.9% revenue growth.

Moderna (NASDAQ:MRNA) presented Phase 3 results for intismeran, its individualized neoantigen therapy, in combination with Merck’s pembrolizumab for patients with resected high-risk melanoma. The INTerpath-001 trial met its primary endpoint of relapse-free survival and a key secondary endpoint of di

The stock is down 46% over the past year.

Owning the S&P 500 index isn't as diversified of a strategy as you might initially assume.

Oil prices are high, which is a relatively greater benefit to Occidental, but what happens when commodity prices fall?

Cybersecurity as it pertains to AI agents is rapidly becoming an issue that could make Ethereum more valuable.

Not all dividend payers are built the same.

Parabilis Medicines (NASDAQ:PBLS) presented updated interim phase I/II data for investigational beta-catenin/TCF inhibitor zolucatetide in desmoid tumors at the European Society for Medical Oncology Congress in Madrid, reporting tumor responses, disease control and an FDA-aligned plan for a registra

What would management's 2028 goals make the stock worth by 2030?